Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0916 in Type 2 Diabetes and Metabolic Syndrome
NCT00543595Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
Phase 2 trial of MK-0916 in type 2 diabetes mellitus (T2DM) and metabolic syndrome, sponsored by Merck & Co. Started Aug 2004; status: completed.
02
Drugs
MK-0916
03
Conditions
type 2 diabetes mellitus (T2DM)metabolic syndrome
Beyond the preview
Go deeper on NCT00543595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543595.